InvestWiser

Zenicor Medical Systems AB

ZENINasdaq StockholmHealthcareMarket value 18 m SEK
0.67SEK −14.1%
last day · Price as of 19 November 2026

The answer first

Does Zenicor Medical Systems beat the market?

No, Zenicor Medical Systems has not beaten the market over the last year.

Zenicor Medical Systems−48.5%Stockholm (OMXSGI)+17.6%

Max for seven days

Follow Zenicor Medical Systems with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Zenicor Medical Systems

From today, at a price of 0.67 SEK. Write why you follow Zenicor Medical Systems, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Zenicor Medical Systems

Your first answer is free, no account needed.

Do you own Zenicor Medical Systems, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Zenicor Medical Systems and a few more. Free, no card.

Past year against the exchange and Super Stock
Zenicor Medical Systems−48.5%Stockholm (OMXSGI)+17.6%Super Stock+46.4%
14 November 202519 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Zenicor Medical Systems has fallen 48.5% over the past year, including dividends.
  • The largest fall over the past three years was 95.4%. The price is 98.5% below its peak now.

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

Quality–
The company · Fundamentals: the accounts
  • Debt to equityBorrowings divided by equity0.11
  • Asset turnoverSales divided by everything the company owns0.37
  • Return on equityProfit divided by equity+1.8%
  • Cash conversionOperating cash flow divided by profit−8.87

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value–
The price · Valuation: the multiples
  • P/BPrice divided by equity0.3
  • P/SPrice divided by sales0.6
  • P/EPrice divided by earnings16.4
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend–
The share price · Technical: the price trend
  • 3 months−35.0%
  • 6 months−43.7%
  • 9 months−38.0%
  • 12 months−48.5%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−24.3%
3 years, per year
−42.0%
5 years, per year
−51.1%
10 years, per year
−27.5%
Largest fall, 3 years
−95.4%
From a peak to the bottom
From the peak now
−98.5%
How far the price is from the peak
Volatility, 1 year
80.1%
How much the price swings over a year
Beta, 1 year
−0.49
How much the price moves when the market moves

Return with dividends reinvested.

About Zenicor Medical Systems

Zenicor Medical Systems AB is a company in healthcare, listed on Nasdaq Stockholm. By market value, Zenicor Medical Systems is number 119 of 137 companies in healthcare on Nasdaq Stockholm. Zenicor Medical Systems has not paid a dividend in the past twelve months. The share trades in SEK. It has around 20 employees.

Zenicor Medical Systems AB (publ), a medical technology company, develops systems and care chains for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor One, a handheld ECG device for arrhythmia; Zenicor Flex, a device that provides ECG data and arrhythmia detection; and Zenicor View, a web-based system solution for all types of arrhythmia investigations. It also provides Zenicor Direct, a solution with interpretation services and services for device logistics; and DeepRhythmAI, an AI technology of Zenicor Solution for modern arrhythmia diagnostics. The company was incorporated in 2003 and is headquartered in Stockholm, Sweden.

See the full analysis of Zenicor Medical Systems.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market